Share
Other content recommended for you
- Intravenous immunoglobulin in neurological disease: a specialist review
- Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn
- GRP-063 Evaluation of Intravenous Immunoglobulin (IVIG) Prescriptions in an Italian Paediatric Hospital: An Overview of Off-Label Uses
- DI-023 Analysis of intravenous immunoglobulin use in a tertiary hospital and evaluation of its economic impact
- DI-045 Analysis of the use of intravenous inmunoglobulins
- Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial
- A utilisation review of intravenous immunoglobulin in a tertiary care hospital in United Arab Emirates
- Guillain-Barré syndrome as first presentation of systemic lupus erythematosus: a rare manifestation complicated by IVIg-induced splenic infarct
- CP-038 Use and economic impact of intravenous immunoglobulin at a university hospital
- QUESTION 2